Direct differentiation of homogeneous human adipose stem cells into functional hepatocytes by mimicking liver embryogenesis

Journal of Cellular Physiology

Volumn 229, Issue 6, 2014, Pages 801-812

  Li, Xueyang ^a   Yuan, Jie ^a   Li, Weihong ^a   Liu, Sicheng ^a   Hua, Mingxi ^a   Lu, Xin ^a   Zhang, Haiyan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVIN A; ALBUMIN; BONE MORPHOGENETIC PROTEIN 2; CELL MARKER; CYTOCHROME P450; DEXAMETHASONE; ENDOGLIN; FIBROBLAST GROWTH FACTOR 4; GLYCOGEN; HEPATOCYTE NUCLEAR FACTOR 3BETA; MULTIDRUG RESISTANCE PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOSTATIN M; SCATTER FACTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2;

ADIPOSE DERIVED STEM CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO DEVELOPMENT; ENDODERM; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL; LIVER DEVELOPMENT; MULTIPOTENT STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UREA CYCLE;

ACTIVINS; ADIPOCYTES; ADULT; CELL DIFFERENTIATION; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIVER; MIDDLE AGED; STEM CELLS;

EID: 84894283053     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24501     Document Type: Article

References (42)

1. Allen KJ, Buck NE, Williamson R. 2005. Stem cells for the treatment of liver disease. Transpl Immunol 15:99-112.
2. Aurich H, Sgodda M, Kaltwasser P, Vetter M, Weise A, Liehr T, Brulport M, Hengstler JG, Dollinger MM, Fleig WE, Christ B. 2009. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58:570-581.
3. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T. 2007. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46:219-228.
4. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kato T, Okochi H, Ochiya T. 2009. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24:70-77.
5. Baxter MA, Rowe C, Alder J, Harrison S, Hanley KP, Park BK, Kitteringham NR, Goldring CE, Hanley NA. 2010. Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res 5:4-22.
6. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. 2005. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
7. Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, Meng S, Chen Y, Zhou R, Song X, Guo Y, Ding M, Deng H. 2007. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45:1229-1239.
8. Cawthorn WP, Scheller EL, MacDougald OA. 2012. Adipose tissue stem cells: The great WAT hope. Trends Endocrinol Metab 23:270-277.
9. Chamberlain G, Fox J, Ashton B, Middleton J. 2007. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739-2749.
10. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. 2005. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23:1534-1541.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
12. Dufort D, Schwartz L, Harpal K, Rossant J. 1998. The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development 125:3015-3025.
13. Gadue P, Huber TL, Paddison PJ, Keller GM. 2006. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci USA 103:16806-16811.
14. Greco SJ, Liu K, Rameshwar P. 2007. Functional similarities among genes regulated by Oct4 in human mesenchymal and embryonic stem cells. Stem Cells 25:3143-3154.
15. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, Gimble JM. 2006. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 206:229-237.
16. Hua M, Zhang W, Li W, Li X, Liu B, Lu X, Zhang H. 2012. Molecular mechanisms regulating the establishment of hepatocyte polarity during human hepatic progenitor cell differentiation into a functional hepatocyte-like phenotype. J Cell Sci 125:5800-5810.
17. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. 2002. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62:65-74.
18. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA. 2006. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99:1285-1297.
19. Kauts ML, Pihelgas S, Orro K, Neuman T, Piirsoo A. 2013. CCL5/CCR1 axis regulates multipotency of human adipose tissue derived stromal cells. Stem Cell Res 10:166-178.
20. Lemaigre FP. 2009. Mechanisms of liver development: Concepts for understanding liver disorders and design of novel therapies. Gastroenterology 137:62-79.
21. Martinez Barbera JP, Clements M, Thomas P, Rodriguez T, Meloy D, Kioussis D, Beddington RS. 2000. The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127:2433-2445.
22. Morrison GM, Oikonomopoulou I, Migueles RP, Soneji S, Livigni A, Enver T, Brickman JM. 2008. Anterior definitive endoderm from ESCs reveals a role for FGF signaling. Cell Stem Cell 3:402-415.
23. Okura H, Komoda H, Saga A, Kakuta-Yamamoto A, Hamada Y, Fumimoto Y, Lee CM, Ichinose A, Sawa Y, Matsuyama A. 2010. Properties of hepatocyte-like cell clusters from human adipose tissue-derived mesenchymal stem cells. Tissue Eng Part C Methods 16:761-770.
24. Pan GJ, Thomson JA. 2007. Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17:42-49.
25. Pierantozzi E, Gava B, Manini I, Roviello F, Marotta G, Chiavarelli M, Sorrentino V. 2011. Pluripotency regulators in human mesenchymal stem cells: Expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev 20:915-923.
26. Piscaglia AC, Campanale M, Gasbarrini A, Gasbarrini G. 2010. Stem cell-based therapies for liver diseases: State of the art and new perspectives. Stem Cells Int 2010:259461.
27. Roelandt P, Sancho-Bru P, Pauwelyn K, Verfaillie C. 2010. Differentiation of rat multipotent adult progenitor cells to functional hepatocyte-like cells by mimicking embryonic liver development. Nat Protoc 5:1324-1336.
28. Seo MJ, Suh SY, Bae YC, Jung JS. 2005. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res Commun 328:258-264.
29. Snykers S, De Kock J, Rogiers V, Vanhaecke T. 2009. In vitro differentiation of embryonic and adult stem cells into hepatocytes: State of the art. Stem Cells 27:577-605.
30. Talens-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, Gomez-Lechon MJ. 2007. Human mesenchymal stem cells from adipose tissue: Differentiation into hepatic lineage. Toxicol In Vitro 21:324-329.
31. Tallone T, Realini C, Bohmler A, Kornfeld C, Vassalli G, Moccetti T, Bardelli S, Soldati G. 2011. Adult human adipose tissue contains several types of multipotent cells. J Cardiovasc Transl Res 4:200-210.
32. Tsai CC, Su PF, Huang YF, Yew TL, Hung SC. 2012. Oct4 and Nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Mol Cell 47:169-182.
33. Wu Q, Chen X, Zhang J, Loh YH, Low TY, Zhang W, Sze SK, Lim B, Ng HH. 2006. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem 281:24090-24094.
34. Xu X, Browning VL, Odorico JS. 2011. Activin, BMP and FGF pathways cooperate to promote endoderm and pancreatic lineage cell differentiation from human embryonic stem cells. Mech Dev 128:412-427.
35. Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KL. 2003. Pharmacokinetics of 5 (and 6)-carboxy-2', 7'-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801-809.
36. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P, Lim B. 2006. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8:1114-1123.
37. Zhang W, Li W, Liu B, Wang P, Zhang H. 2012. Efficient generation of functional hepatocyte-like cells from human fetal hepatic progenitor cells in vitro. J Cell Physiol 227:2051-2058.
38. Zorn AM. 2008. Liver development. Cambridge, MA: StemBook.
39. Zorn AM, Wells JM. 2007. Molecular basis of vertebrate endoderm development. Int Rev Cytol 259:49-111.
40. Zuk PA. 2009. The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used. J Cell Biochem 106:867-877.
41. Zuk PA. 2010. The adipose-derived stem cell: Looking back and looking ahead. Mol Biol Cell 21:1783-1787.
42. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. 2001. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.